3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine

C135H282N22 — CID 163502290

IUPAC3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine
SMILESCC(C)C1CCN(C(C)C)CC1.CC(C)N1CC2CCC(C1)N2C(C)C.CC(C)N1CCC2(C1)CN(C(C)C)C2.CC(C)N1CCC2(CC1)CCN(C(C)C)C2.CC(C)N1CCC2(CC1)CCN(C(C)C)C2.CC(C)N1CCCN(C(C)C)CC1.CC(C)N1CCCN(C(C)C)[C@@H](C)C1.CC(C)N1CCCN(C(C)C)[C@@H](C)C1.CC(C)N1CCN(C2CN(C(C)C)C2)CC1.CC(C)N1CC[C@H](C)N(C(C)C)CC1.CC(C)N1CC[C@H](C)N(C(C)C)CC1
InChIInChI=1S/2C14H28N2.C13H27N3.2C12H24N2.4C12H26N2.C11H24N2.C11H23N/c2*1-12(2)15-8-5-14(6-9-15)7-10-16(11-14)13(3)4;1-11(2)14-5-7-15(8-6-14)13-9-16(10-13)12(3)4;1-10(2)13-6-5-12(7-13)8-14(9-12)11(3)4;1-9(2)13-7-11-5-6-12(8-13)14(11)10(3)4;2*1-10(2)13-7-6-12(5)14(9-8-13)11(3)4;2*1-10(2)13-7-6-8-14(11(3)4)12(5)9-13;1-10(2)12-6-5-7-13(9-8-12)11(3)4;1-9(2)11-5-7-12(8-6-11)10(3)4/h2*12-13H,5-11H2,1-4H3;11-13H,5-10H2,1-4H3;10-11H,5-9H2,1-4H3;9-12H,5-8H2,1-4H3;4*10-12H,6-9H2,1-5H3;10-11H,5-9H2,1-4H3;9-11H,5-8H2,1-4H3/t;;;;;4*12-;;/m.....0000../s1
InChIKeyCVUFDIIDGYIGKZ-JESHKWGDSA-N
MW2213.89 g/mol
LogP23.42
Rot. Bonds23

About 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine

3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine (PubChem CID 163502290) has the molecular formula C135H282N22 and a molecular weight of 2213.89 g/mol. Its IUPAC name is 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine.

Molecular Properties

Compound Name3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine
PubChem CID163502290
Molecular FormulaC135H282N22
Molecular Weight2213.89 g/mol
Exact Mass2212.27
IUPAC Name3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine
SMILESCC(C)C1CCN(C(C)C)CC1.CC(C)N1CC2CCC(C1)N2C(C)C.CC(C)N1CCC2(C1)CN(C(C)C)C2.CC(C)N1CCC2(CC1)CCN(C(C)C)C2.CC(C)N1CCC2(CC1)CCN(C(C)C)C2.CC(C)N1CCCN(C(C)C)CC1.CC(C)N1CCCN(C(C)C)[C@@H](C)C1.CC(C)N1CCCN(C(C)C)[C@@H](C)C1.CC(C)N1CCN(C2CN(C(C)C)C2)CC1.CC(C)N1CC[C@H](C)N(C(C)C)CC1.CC(C)N1CC[C@H](C)N(C(C)C)CC1
InChIInChI=1S/2C14H28N2.C13H27N3.2C12H24N2.4C12H26N2.C11H24N2.C11H23N/c2*1-12(2)15-8-5-14(6-9-15)7-10-16(11-14)13(3)4;1-11(2)14-5-7-15(8-6-14)13-9-16(10-13)12(3)4;1-10(2)13-6-5-12(7-13)8-14(9-12)11(3)4;1-9(2)13-7-11-5-6-12(8-13)14(11)10(3)4;2*1-10(2)13-7-6-12(5)14(9-8-13)11(3)4;2*1-10(2)13-7-6-8-14(11(3)4)12(5)9-13;1-10(2)12-6-5-7-13(9-8-12)11(3)4;1-9(2)11-5-7-12(8-6-11)10(3)4/h2*12-13H,5-11H2,1-4H3;11-13H,5-10H2,1-4H3;10-11H,5-9H2,1-4H3;9-12H,5-8H2,1-4H3;4*10-12H,6-9H2,1-5H3;10-11H,5-9H2,1-4H3;9-11H,5-8H2,1-4H3/t;;;;;4*12-;;/m.....0000../s1
InChIKeyCVUFDIIDGYIGKZ-JESHKWGDSA-N
XLogP23.42
TPSA71.28 Ų
H-Bond Donors
H-Bond Acceptors22
Rotatable Bonds23
Heavy Atoms157
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002213.89
LogP ≤ 523.42
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1022

Analyze 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-Tert-butyl-4-methyl-4-propan-2-ylpiperidine;1-tert-butyl-4-propan-2-ylpiperazine;1-tert-butyl-4-propan-2-ylpiperidine;2,5-ditert-butyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2,7-ditert-butyl-1,3,4,4a,5,6,8,8a-octahydro-2,7-naphthyridine;1,3-ditert-butylazetidine;2,8-ditert-butyl-2,8-diazaspiro[4.5]decane;2,6-ditert-butyl-2,6-diazaspiro[3.3]heptane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;2,9-ditert-butyl-2,9-diazaspiro[5.5]undecane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane;1,3-ditert-butylpyrrolidine
CID 157218252
bis(2,2-dimethyl-1,4-di(propan-2-yl)piperazine);(1S,4S)-2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;(1R,5S)-3,6-di(propan-2-yl)-3,6-diazabicyclo[3.2.0]heptane;bis((1S,5R)-3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane);bis(2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane);1,4-di(propan-2-yl)-1,4-diazepane;1,5-di(propan-2-yl)-1,5-diazocane;1,4-di(propan-2-yl)piperazine;(2S)-1,4-di(propan-2-yl)piperazine-2-carbonitrile;(3R)-1,3-di(propan-2-yl)pyrrolidine;(3S)-1,3-di(propan-2-yl)pyrrolidine;(2R)-2-ethyl-1,4-di(propan-2-yl)piperazine;(2R)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(5R)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane;(2R)-2-methyl-1,4-di(propan-2-yl)piperazine;bis((2S)-2-methyl-1,4-di(propan-2-yl)piperazine)
CID 157347072
4-Tert-butyl-1,4-diazabicyclo[3.2.2]nonane;4-tert-butyl-1,4-diazabicyclo[3.2.1]octane;2-tert-butyl-5-methyl-2,5-diazabicyclo[2.2.1]heptane;3-tert-butyl-8-methyl-3,8-diazabicyclo[3.2.1]octane;3-tert-butyl-1,5,7-trimethyl-3,7-diazabicyclo[3.3.1]nonane;methane
CID 157376407
N-(azepan-4-ylmethyl)-N-methylpropan-2-amine;N-(azepan-4-ylmethyl)propan-2-amine;bis(N-(azetidin-3-ylmethyl)propan-2-amine);N-ethyl-N-propan-2-ylazepan-4-amine;N-ethyl-N-propan-2-ylazetidin-3-amine;N-ethyl-N-propan-2-ylpiperidin-4-amine;N-ethyl-N-propan-2-ylpyrrolidin-3-amine;methane;N-methyl-N-(piperidin-4-ylmethyl)propan-2-amine;N-methyl-N-propan-2-ylazepan-4-amine;N-methyl-N-propan-2-ylazetidin-3-amine;N-methyl-N-propan-2-ylpiperidin-4-amine;N-methyl-N-propan-2-ylpyrrolidin-3-amine;N-(piperidin-4-ylmethyl)propan-2-amine;N-propan-2-ylazepan-4-amine;N-propan-2-ylazetidin-3-amine;N-propan-2-ylpiperidin-4-amine;N-propan-2-ylpyrrolidin-3-amine;bis(N-(pyrrolidin-3-ylmethyl)propan-2-amine)
CID 157642509
3,6-Di(propan-2-yl)-3,6-diazabicyclo[3.1.1]heptane;6-methyl-3-propan-2-yl-3-azabicyclo[3.1.1]heptane;3-methyl-8-propan-2-yl-8-azabicyclo[3.2.1]octane;2-methyl-5-propan-2-yl-2,5-diazabicyclo[2.2.1]heptane;6-methyl-3-propan-2-yl-3,6-diazabicyclo[3.1.1]heptane;3-methyl-8-propan-2-yl-3,8-diazabicyclo[3.2.1]octane;8-methyl-3-propan-2-yl-3,8-diazabicyclo[3.2.1]octane
CID 157671451
2,5-Bis(2-methylpropyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;bis(2,5-bis(2-methylpropyl)-2,5-diazabicyclo[2.2.1]heptane);bis(2,5-bis(2-methylpropyl)-2,5-diazabicyclo[2.2.2]octane);3,6-bis(2-methylpropyl)-3,6-diazabicyclo[3.2.1]octane;bis(2,8-bis(2-methylpropyl)-2,8-diazaspiro[4.5]decane);bis(2,7-bis(2-methylpropyl)-2,7-diazaspiro[3.5]nonane);3,9-bis(2-methylpropyl)-3,9-diazaspiro[5.5]undecane;1,4-bis(2-methylpropyl)piperazine;bis(1,4-bis(2-methylpropyl)piperidine);6-(2,2-dimethylpropyl)-3-(2-methylpropyl)-3,6-diazabicyclo[3.2.1]octane;ethane
CID 157689894
CID 157797983
CID 157797983
bis(1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperidine);bis(1-tert-butyl-4-[(3-tert-butylazetidin-1-yl)methyl]piperidine);bis(4-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine);bis(1-tert-butyl-4-[(4-tert-butylpiperidin-1-yl)methyl]piperidine);bis(4-tert-butyl-1-[[(3S)-1-tert-butylpyrrolidin-3-yl]methyl]piperidine);bis(4-tert-butyl-1-[[(3R)-1-tert-butylpyrrolidin-3-yl]methyl]piperidine)
CID 158176484
1-Tert-butyl-4-[(3-tert-butylazetidin-1-yl)methyl]piperidine;4-tert-butyl-1-(1-tert-butylazetidin-3-yl)-4-methylpiperidine;1-tert-butyl-4-(3-tert-butylazetidin-1-yl)piperidine;4-tert-butyl-1-(1-tert-butylazetidin-3-yl)piperidine;1-tert-butyl-4-[(4-tert-butylpiperidin-1-yl)methyl]piperidine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;4-tert-butyl-1-[(1-tert-butylpyrrolidin-3-yl)methyl]-4-methylpiperidine;1-tert-butyl-4-[(1-tert-butylpyrrolidin-3-yl)methyl]piperazine;5-tert-butyl-2-(2,2-dimethylpropyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole
CID 158243569
2,2-Dimethyl-1,4-di(propan-2-yl)piperazine;3,8-di(propan-2-yl)-8-azabicyclo[3.2.1]octane;2,5-di(propan-2-yl)-2,5-diazabicyclo[2.2.1]heptane;3,6-di(propan-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;1,4-di(propan-2-yl)piperazine
CID 158562511
2,5-di(propan-2-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium;1,4-di(propan-2-yl)-4-aza-1-azoniabicyclo[3.2.2]nonane;1,4-di(propan-2-yl)-4-aza-1-azoniabicyclo[3.2.1]octane;1,4-di(propan-2-yl)-1-azoniabicyclo[2.2.2]octane;1,1-di(propan-2-yl)pyrrolidin-1-ium;2-methyl-2,5-di(propan-2-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane
CID 158877274
2-Tert-butyl-6-methyl-2,6-diazaspiro[4.5]decane;2-tert-butyl-9-methyl-2,9-diazaspiro[4.5]decane;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;2-tert-butyl-8-methyl-2,8-diazaspiro[3.5]nonane;7-tert-butyl-1-methyl-1,7-diazaspiro[3.5]nonane;2-tert-butyl-5-methyl-2,5-diazaspiro[3.4]octane;2-tert-butyl-7-methyl-2,7-diazaspiro[3.4]octane;1-methyl-8-propan-2-yl-1,8-diazaspiro[4.5]decane;8-methyl-2-propan-2-yl-2,8-diazaspiro[4.5]decane;6-methyl-2-propan-2-yl-2,6-diazaspiro[3.3]heptane;1-methyl-8-propan-2-yl-1,8-diazaspiro[3.5]nonane;2-methyl-7-propan-2-yl-2,7-diazaspiro[3.5]nonane
CID 158887942

Frequently Asked Questions

What is the IUPAC name of 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine?
The IUPAC name of 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine (CID 163502290) is 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine.
What is the SMILES notation for 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine?
The canonical SMILES for 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine is CC(C)C1CCN(C(C)C)CC1.CC(C)N1CC2CCC(C1)N2C(C)C.CC(C)N1CCC2(C1)CN(C(C)C)C2.CC(C)N1CCC2(CC1)CCN(C(C)C)C2.CC(C)N1CCC2(CC1)CCN(C(C)C)C2.CC(C)N1CCCN(C(C)C)CC1.CC(C)N1CCCN(C(C)C)[C@@H](C)C1.CC(C)N1CCCN(C(C)C)[C@@H](C)C1.CC(C)N1CCN(C2CN(C(C)C)C2)CC1.CC(C)N1CC[C@H](C)N(C(C)C)CC1.CC(C)N1CC[C@H](C)N(C(C)C)CC1.
What is the InChIKey of 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine?
The InChIKey is CVUFDIIDGYIGKZ-JESHKWGDSA-N. The full InChI is InChI=1S/2C14H28N2.C13H27N3.2C12H24N2.4C12H26N2.C11H24N2.C11H23N/c2*1-12(2)15-8-5-14(6-9-15)7-10-16(11-14)13(3)4;1-11(2)14-5-7-15(8-6-14)13-9-16(10-13)12(3)4;1-10(2)13-6-5-12(7-13)8-14(9-12)11(3)4;1-9(2)13-7-11-5-6-12(8-13)14(11)10(3)4;2*1-10(2)13-7-6-12(5)14(9-8-13)11(3)4;2*1-10(2)13-7-6-8-14(11(3)4)12(5)9-13;1-10(2)12-6-5-7-13(9-8-12)11(3)4;1-9(2)11-5-7-12(8-6-11)10(3)4/h2*12-13H,5-11H2,1-4H3;11-13H,5-10H2,1-4H3;10-11H,5-9H2,1-4H3;9-12H,5-8H2,1-4H3;4*10-12H,6-9H2,1-5H3;10-11H,5-9H2,1-4H3;9-11H,5-8H2,1-4H3/t;;;;;4*12-;;/m.....0000../s1.
What are the key properties of 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine?
3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine has a molecular weight of 2213.89 g/mol, XLogP of 23.42, 23 rotatable bonds, 0 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 3,8-di(propan-2-yl)-3,8-diazabicyclo[3.2.1]octane;bis(2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decane);2,7-di(propan-2-yl)-2,7-diazaspiro[3.4]octane;1,4-di(propan-2-yl)-1,4-diazepane;1,4-di(propan-2-yl)piperidine;bis((2S)-2-methyl-1,4-di(propan-2-yl)-1,4-diazepane);bis((5S)-5-methyl-1,4-di(propan-2-yl)-1,4-diazepane);1-propan-2-yl-4-(1-propan-2-ylazetidin-3-yl)piperazine is sourced from PubChem (CID 163502290), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).